IBIS-Survivorship - Breast Cancer

“By sharing the care of patients with cancer between their specialist and GP, and shifting the focus of follow-up care away from the hospital, we believe we can increase the quality and efficiency of care, as well as make it more cost effective and satisfactory for patients.”

- Chan

Breast cancer is the most diagnosed cancer in Australia, with an estimated 19,535 Australian patients diagnosed with breast cancer in 2019. Due to significant technology advancements and better early detection, the 5-year survival rate exceeds 90%, thus, there is a high demand for cancer survivorship support. Current models of care are specialist driven and surveillance focused.

The EMINENT trial demonstrated feasibility and success of a nurse-coordinated, shared-care follow up model. The IBIS-survivorship trial seeks to build on, and upscale, the EMINENT trial.

Goal

The IBIS-survivorship randomised controlled clinical trial follows and builds on the success of the EMINENT trial. The IBIS trial is a national study investigating a nurse coordinated, shared-care model over eight sites. The expansion of this model to other facilities aims to better understand the system implications and identify barriers to the model.

Aims

To assess the effectiveness and cost effectiveness of a nurse-coordinated, share-care follow-up model of care (IBIS survivorship model of care)

To demonstrate that General Practitioners may provide a holistic approach to care, facilitate a healthy lifestyle to prevent further chronic illness and offer greater patient satisfaction and flexibility in appointment intervals.

Researchers

From Flinders

Professor Raymond Chan
Dr Nicolas Hart
Professor Bogda Koczwara
Dr Fiona Crawford-Williams

Research Collaborators

Laisa Teleni
Bethany Crowe
Kerry Patford
Distinguished Professor Patsy Yates
Professor Jon Emery
Professor Bruce Mann
Professor Elizabeth Eakin
Professor Jane Turner
Professor Mei Krishnasamy
Associate Professor Louisa Gordon
Dr Carla Thamm

Grant Details

NHMRC Partnership Grant - $1,444,032

Chief Investigators:

Professor Raymond Chan Distinguished Professor Pasty Yates
Professor Bogda Koczwara Professor Jon Emery
Professor Bruce Mann
Professor Elizabeth Eakin
Professor Jane Turner
Professor Mei Krishnasamy,
Associate Professor Louisa Gordon
Dr Helen Skerman

Commenced: 2020
Completion due: 2028

Tools and Resources

Researchers address frequently asked questions (FAQs) about the IBIS-Survivorship study

Collaborators

Associate Investigators: Professor Geoff Mitchell, Associate Professor Paul Craft, Associate Professor Kim Alexander, Associate Professor Larisa Haupt, Professor Karla Hemming, Professor Russell Glasgow, Professor Leanne Monterosso, Ms Gillian Blanchard, Ms Shirley Baxter, Adjunct Associate Professor Violet Platt, Adjunct Professor Leanne Stone, Professor Alexandre Chan.

Site Investigators: Brisbane: Associate Professor Doreen Tapsall; Canberra: Associate Professor Paul Craft, Dr Yada Kanjanapan & Dr Amy Shorthouse; Gold Coast: Professor Jasotha Sanmugarajah & Associate Professor Rhea Liang; Ipswich: Ruth McCaffrey & Erin Downs; Sunshine Coast: Dr Mary Azar, Dr Bryan Chan, Dr Michelle Morris & Dr Kathleen Houston; Newcastle: Gillian Blanchard